Clinical Trial

Anti CD19 Gene Therapy for B-cell Lymphoma

Name: Anti CD19 Gene Therapy for B-cell Lymphoma — clinical trial record (NCT07211048)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is an open label, single-site, dose-escalation study in up to 18 participants with treatment of relapsed/refractory B-cell lymphoma. This study aims to evaluate the safety and efficacy of the treatment with an Anti- CD19 gene injection

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-30.

Trial Details

NCT Number	NCT07211048
Lead Sponsor	Anhui Provincial Hospital
Conditions	B-cell Lymphoma
Enrollment	18 participants
Start Date	2026-03-20
Primary Completion	2029-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-21